Maternal mannan-oligosaccharide (MOS) supplementation during pregnancy and nursing significantly improved offspring digestive resilience in a 2026 study of 60 pigs. Baby pigs born to MOS-supplemented mothers gained 15% more weight before weaning, produced stronger intestinal barrier proteins, and showed 14% less intestinal inflammation when exposed to an immune challenge compared to control piglets. The supplement enhanced protective antibodies and fat content in mothers’ milk, creating a protective effect that lasted through weaning. According to Gram Research analysis, this finding suggests maternal nutrition directly influences offspring gut health and stress resilience, though human studies are needed to confirm these effects in people.
A new study shows that when pregnant pigs received a special supplement called mannan-oligosaccharide (MOS), their babies had stronger, healthier digestive systems after weaning. The supplement helped mothers produce milk with more protective antibodies and nutrients. When the baby pigs faced a stressful immune challenge at weaning, those born to supplemented mothers showed better intestinal protection and less inflammation. According to Gram Research analysis, this finding suggests that what mothers eat during pregnancy and nursing directly affects how well their babies’ guts can handle stress and stay healthy during major life transitions.
Key Statistics
A 2026 research study of 60 pregnant pigs found that maternal mannan-oligosaccharide supplementation increased baby piglet daily weight gain by 15% (224 grams versus 195 grams per day) and weaning weight by 13% (6.67 kilograms versus 5.91 kilograms) compared to control offspring.
Mothers receiving mannan-oligosaccharide supplementation produced colostrum with 39% more IgA antibodies (5.37 versus 3.00 milligrams per milliliter) and 38% more fat (5.26% versus 3.80%) than control mothers, according to a 2026 animal nutrition study.
In a 2026 pig study, offspring of mannan-oligosaccharide-supplemented mothers showed 14% lower intestinal inflammation (IL-1 beta levels of 146.31 versus 169.77 picograms per milliliter) when challenged with an immune stressor at weaning compared to control piglets.
Maternal mannan-oligosaccharide supplementation increased jejunal occludin protein expression by 77% (0.78 versus 0.44 normalized units) in weaned piglets exposed to immune challenge, indicating stronger intestinal barrier function in a 2026 research study.
The Quick Take
- What they studied: Whether giving pregnant and nursing pigs a natural supplement called MOS would help their babies develop stronger, more resilient digestive systems that could better handle stress after weaning.
- Who participated: Sixty pregnant pigs were divided into two groups: 30 received the MOS supplement and 30 received a regular diet. Researchers then tested the baby pigs at weaning to see how well their digestive systems handled an immune challenge.
- Key finding: Baby pigs born to mothers who received MOS had 15% higher daily weight gain before weaning, stronger intestinal barrier proteins, and 14% less intestinal inflammation when challenged with an immune stressor compared to control piglets.
- What it means for you: This research suggests that maternal nutrition during pregnancy and nursing may have lasting effects on offspring digestive health and resilience. While this study was in pigs, the findings could eventually inform human nutrition strategies for pregnant and nursing mothers, though more research is needed before making specific recommendations.
The Research Details
Researchers divided 60 pregnant pigs into two groups. One group received a supplement called mannan-oligosaccharide (MOS), a natural fiber derived from yeast, mixed into their feed at 800 milligrams per kilogram. The other group received regular feed without the supplement. Both groups were fed this way from day 85 of pregnancy through day 21 of nursing. The researchers collected samples of the mothers’ milk and feces, and measured how well the baby pigs grew. At weaning, they tested 24 of the baby pigs by giving some an immune challenge (a substance called lipopolysaccharide) to see how their digestive systems would respond. They then measured inflammation, intestinal barrier strength, and antioxidant levels in the piglets’ blood and intestinal tissue.
This study design is important because it looks at how maternal nutrition affects not just immediate growth, but also long-term resilience and stress response in offspring. By measuring milk composition and then testing the babies’ intestinal responses to an immune challenge, researchers could trace a direct path from what mothers ate to how well their babies’ guts functioned under stress. This approach is more realistic than just measuring growth alone.
This study was published in The Journal of Nutrition, a peer-reviewed scientific journal. The researchers used controlled conditions with clear measurement methods and accounted for litter effects in their statistical analysis. The sample size of 60 mothers is moderate for this type of animal research. The study included multiple measurements of milk composition and intestinal function, which strengthens confidence in the findings. However, this is animal research in pigs, so results may not directly transfer to humans without further study.
What the Results Show
Mothers who received MOS ate about 9% more food during nursing (5.68 kilograms per day versus 5.21 kilograms per day), which suggests the supplement may have improved their appetite or feed efficiency. Their baby pigs grew significantly faster before weaning, gaining an average of 224 grams per day compared to 195 grams per day in the control group, a difference of about 15%. At weaning, the MOS-supplemented group’s piglets weighed 6.67 kilograms compared to 5.91 kilograms in the control group. When researchers tested the baby pigs’ intestinal response to an immune challenge, those born to MOS-supplemented mothers showed stronger intestinal barrier proteins (occludin) and less intestinal inflammation (lower IL-1 beta levels). These differences suggest that maternal MOS supplementation created a protective effect that lasted through weaning and helped piglets handle stress better.
The milk from MOS-supplemented mothers contained significantly more protective antibodies and fat. Colostrum (first milk) from supplemented mothers had 5.26% fat and 5.37 milligrams per milliliter of IgA antibodies, compared to 3.80% fat and 3.00 milligrams per milliliter in control mothers. By day 14 of nursing, these differences persisted: supplemented mothers’ milk had 7.72% fat and 0.43 milligrams per milliliter of IgA, versus 5.19% fat and 0.19 milligrams per milliliter in controls. These findings show that MOS supplementation improved the nutritional and immune quality of milk, which likely explains why the baby pigs had better intestinal resilience.
Previous research has shown that prebiotics like MOS can improve gut health in animals, but most studies focused on direct supplementation of the animals themselves. This study adds to that knowledge by showing that maternal supplementation during pregnancy and nursing can transfer protective benefits to offspring through milk. The finding that maternal nutrition influences milk composition and offspring resilience aligns with existing research on how early-life nutrition shapes long-term health, though the specific mechanism through MOS is relatively novel.
This study was conducted in pigs, not humans, so the results may not directly apply to human pregnancy and nursing. The sample size of 60 mothers is moderate, which means some findings might not hold up in larger studies. The immune challenge test was done at a single time point (6 hours after the challenge), so researchers did not measure how long the protective effects lasted. The study did not measure all possible markers of intestinal health or immune function. Finally, this research was funded by sources that may have commercial interest in MOS products, which could influence how results are interpreted, though the study appears to be conducted with scientific rigor.
The Bottom Line
Based on this research, there is moderate evidence that maternal supplementation with prebiotics like MOS during pregnancy and nursing may enhance offspring digestive resilience. However, this finding is from animal research and has not yet been tested in humans. Anyone considering maternal supplementation should consult with their healthcare provider, as individual needs vary and safety in human pregnancy must be established through clinical trials. The confidence level for applying these findings to human nutrition is currently low to moderate pending human studies.
This research is most relevant to pregnant and nursing mothers interested in optimizing their nutrition for their babies’ long-term health. It may also interest healthcare providers, nutritionists, and researchers studying early-life nutrition and digestive health. Parents of infants with digestive challenges or immune sensitivities might find this research interesting, though they should not make changes based solely on this animal study. The findings are less immediately relevant to people without plans for pregnancy or nursing.
In this pig study, the protective effects of maternal MOS supplementation were measurable at weaning (around 3 weeks of age in pigs, equivalent to several months in human development). Benefits appeared to develop gradually during pregnancy and nursing. If similar effects occur in humans, benefits would likely develop over months of maternal supplementation during pregnancy and early nursing, with measurable differences in infant digestive health and immune response appearing over the first year of life. More research is needed to establish realistic timelines in humans.
Frequently Asked Questions
Can taking a prebiotic supplement while pregnant help my baby’s digestive health?
A 2026 animal study suggests maternal prebiotic supplementation may enhance offspring digestive resilience and milk quality, but human research is limited. Consult your healthcare provider before starting any supplement during pregnancy, as safety and optimal dosing in humans have not been fully established.
What is mannan-oligosaccharide and where does it come from?
Mannan-oligosaccharide (MOS) is a natural prebiotic fiber derived from yeast cell walls. It feeds beneficial bacteria in the digestive system. The 2026 study used 800 milligrams per kilogram of feed, but human dosing and safety require further research before recommendations can be made.
How does what I eat during pregnancy affect my baby’s gut bacteria?
Maternal diet influences milk composition, which directly transfers nutrients and immune factors to infants. A 2026 study found that maternal prebiotic supplementation increased protective antibodies and fat in milk by 38 to 39%, suggesting maternal nutrition shapes early infant immune development through breastfeeding.
Will my baby have better digestion if I take prebiotics while nursing?
Animal research suggests maternal prebiotic supplementation may improve offspring digestive resilience, but human evidence is limited. Benefits would likely develop gradually over weeks to months of supplementation. Individual results vary, and healthcare provider guidance is essential before starting any supplement.
What foods contain natural prebiotics I can eat while pregnant?
Natural prebiotic sources include garlic, onions, asparagus, bananas, whole grains, and legumes. These foods feed beneficial gut bacteria. While a 2026 study used concentrated MOS supplementation, increasing prebiotic-rich foods is generally considered safe, though discussing dietary changes with your healthcare provider is recommended.
Want to Apply This Research?
- For pregnant or nursing users interested in this research, track daily prebiotic intake (grams of MOS or similar prebiotics), milk production or nursing frequency, and infant digestive symptoms (stool consistency, gas, fussiness) on a weekly basis to monitor patterns and correlations.
- Users could work with their healthcare provider to explore adding prebiotic-rich foods (like garlic, onions, asparagus, or whole grains) or discuss whether a MOS supplement might be appropriate during pregnancy and nursing, while tracking any changes in their own digestion and energy levels.
- Establish a baseline of current prebiotic intake and infant digestive health markers before making changes. After any dietary modifications, monitor weekly for 8 to 12 weeks to assess whether infant digestive comfort, growth rate, or illness frequency changes. Keep detailed notes on maternal diet, supplement use, and infant health observations to share with healthcare providers.
This article summarizes animal research published in The Journal of Nutrition and is not medical advice. The study was conducted in pigs, and results may not directly apply to humans. Pregnant and nursing individuals should not start any supplement, including mannan-oligosaccharide or other prebiotics, without consulting their healthcare provider. Individual nutritional needs vary based on health status, medications, and other factors. This research is preliminary and should not replace evidence-based prenatal or postnatal care. Always discuss dietary changes and supplementation with your doctor or registered dietitian before implementation.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.